We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
MYOS RENS Technology Inc | NASDAQ:MYOS | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.01 | 1.02 | 1.06 | 0 | 01:00:00 |
1. Name and Address of Reporting Person * ABG WTT-MedAvail Ltd | 2. Issuer Name and Ticker or Trading Symbol MedAvail Holdings, Inc. [ MDVL ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director __X__ 10% Owner _____ Officer (give title below) _____ Other (specify below) |
3. Date of Earliest Transaction
(MM/DD/YYYY)
| ||
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
___ Form filed by One Reporting Person
_ X _ Form filed by More than One Reporting Person |
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
1.Title of Security (Instr. 3) | 2. Trans. Date | 2A. Deemed Execution Date, if any |
3. Trans. Code (Instr. 8) |
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) |
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
Code | V | Amount | (A) or (D) | Price | ||||||
Common Stock | 12/28/2020 | P | 3894 | A | $13.9766 (1) | 3878953 | I | See Footnote (2) | ||
Common Stock | 12/28/2020 | P | 3213 | A | $13.9766 (1) | 2915008 | I | See Footnote (3) | ||
Common Stock | 12/29/2020 | P | 55 | A | $14.00 | 3879008 | I | See Footnote (2) | ||
Common Stock | 12/29/2020 | P | 45 | A | $14.00 | 2915053 | I | See Footnote (3) |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
1. Title of Derivate Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Reporting Owners | |||||
Reporting Owner Name / Address | |||||
Director | 10% Owner | Officer | Other | ||
ABG WTT-MedAvail Ltd UNIT 3002-3004, 30TH FLOOR GLOUCESTER TOWER, THE LANDMARK, CENTRAL HONG KONG, K3 | X | ||||
Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. UNIT 3002-3004, 30TH FLOOR GLOUCESTER TOWER, THE LANDMARK, CENTRAL HONG KONG, K3 | X | ||||
ABG-WTT Global Life Science Capital Partners GP, L.P. UNIT 3002-3004, 30TH FLOOR GLOUCESTER TOWER, THE LANDMARK, CENTRAL HONG KONG, K3 | X | ||||
ABG-WTT Global Life Science Capital Partners GP Ltd UNIT 3002-3004, 30TH FLOOR GLOUCESTER TOWER, THE LANDMARK, CENTRAL HONG KONG, K3 | X | ||||
ABG Management Ltd. UNIT 3002-3004, 30TH FLOOR GLOUCESTER TOWER, THE LANDMARK, CENTRAL HONG KONG, K3 | X | ||||
Yu Fan UNIT 3002-3004, 30TH FLOOR GLOUCESTER TOWER, THE LANDMARK, CENTRAL HONG KONG, K3 | X | ||||
Ally Bridge MedAlpha Master Fund L.P. 430 PARK AVENUE, 12TH FLOOR, NEW YORK, NY 10022 | X | ||||
Ally Bridge MedAlpha Management L.P. 430 PARK AVENUE, 12TH FLOOR, NEW YORK, NY 10022 | X | ||||
Ally Bridge MedAlpha Management GP, LLC 430 PARK AVENUE, 12TH FLOOR, NEW YORK, NY 10022 | X | ||||
Ally Bridge Group (NY) LLC 430 PARK AVENUE, 12TH FLOOR, NEW YORK, NY 10022 | X |
Signatures | ||
Ally Bridge Group-WTT Global Life Science Capital Partners, L.P., By: ABG-WTT Global Life Science Capital Partners GP, L.P., its general partner, By: ABG-WTT Global Life Science Capital Partners GP Limited, its general partner, By: /s/ Fan Yu, Director | 12/30/2020 | |
**Signature of Reporting Person | Date | |
ABG-WTT Global Life Science Capital Partners GP, L.P., By: ABG-WTT Global Life Science Capital Partners GP Limited, its general partner, By: /s/ Fan Yu, Director | 12/30/2020 | |
**Signature of Reporting Person | Date | |
ABG-WTT Global Life Science Capital Partners GP Limited, By: /s/ Fan Yu, Director | 12/30/2020 | |
**Signature of Reporting Person | Date | |
Ally Bridge MedAlpha Master Fund L.P., By: Ally Bridge MedAlpha General Partner L.P., its general partner, By: Ally Bridge MedAlpha GP, LLC, its general partner, By: /s/ Fan Yu, Manager | 12/30/2020 | |
**Signature of Reporting Person | Date | |
Ally Bridge MedAlpha Management L.P., By: Ally Bridge MedAlpha Management GP, LLC, its general partner, By: ABG Management Ltd., its managing member, By: /s/ Fan Yu, Director | 12/30/2020 | |
**Signature of Reporting Person | Date | |
Ally Bridge MedAlpha Management GP, LLC, By: ABG Management Ltd., its managing member, By: /s/ Fan Yu, Director | 12/30/2020 | |
**Signature of Reporting Person | Date | |
Ally Bridge Group (NY) LLC, By: ABG Management Ltd., its managing member, By: /s/ Fan Yu, Director | 12/30/2020 | |
**Signature of Reporting Person | Date | |
ABG Management Ltd., By: /s/ Fan Yu, Director | 12/30/2020 | |
**Signature of Reporting Person | Date | |
ABG WTT-MedAvail Limited, By: /s/ Charles Chon, Director | 12/30/2020 | |
**Signature of Reporting Person | Date | |
/s/ Fan Yu | 12/30/2020 | |
**Signature of Reporting Person | Date |
1 Year MYOS RENS Technology Chart |
1 Month MYOS RENS Technology Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions